Evidence map›Paper›PMID 38532642›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2024

Kinetically Controlled Polyelectrolyte Complex Assembly of microRNA-Peptide Nanoparticles toward Treating Mesothelioma.

Caleb F Anderson, Anand Singh, Tyler Stephens, Chuong D Hoang, Joel P Schneider

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Surface-Capped Protein Nanoparticles for Nonviral Gene Delivery.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Intrinsically Disordered Peptide Nanofibers from a Structured Motif Within Proteins.Angewandte Chemie (International ed. in English) · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Caleb F AndersonChemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21701, USA.ORCID https://orcid.org/0000-0003-0760-1928
Anand SinghThoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Tyler StephensVaccine Research Center Electron Microscopy Unit, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 20701, USA.
Chuong D HoangThoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Joel P SchneiderChemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21701, USA.ORCID https://orcid.org/0000-0002-4403-7900

Funding

Design and Utility of Novel Protienaceous BiomaterialsZIABC011313 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNEIDER, JOEL · 2010 to 2025
$19.0M
microRNA regulatory networks in thoracic cancersZIABC011657 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HOANG, CHUONG · 2015 to 2025
$18.1M
Intramural NIH HHS ZIA BC011313NCI NIH HHS ZIABC011313NCI NIH HHS ZIABC011657
6 · The paper itself

Abstract

Broad size distributions and poor long-term colloidal stability of microRNA-carrying nanoparticles, especially those formed by polyelectrolyte complexation, represent major hurdles in realizing their clinical translation. Herein, peptide design is used alongside optimized flash nanocomplexation (FNC) to produce uniform peptide-based miRNA particles of exceptional stability that display anticancer activity against mesothelioma in vitro and in vivo. Modulating the content and display of lysine-based charge from small intrinsically disordered peptides used to complex miRNA proves essential in achieving stable colloids. FNC facilitates kinetic isolation of the mechanistic steps involved in particle formation to allow the preparation of particles of discrete size in a highly reproducible, scalable, and continuous manner, facilitating pre-clinical studies. To the best of the authors knowledge, this work represents the first example of employing FNC to prepare polyelectrolyte complexes of miRNA and peptide. Encapsulation of these particles into an injectable hydrogel matrix allows for their localized in vivo delivery by syringe. A one-time injection of a gel containing particles composed of miRNA-215-5p and the peptide PKM1 limits tumor progression in a xenograft model of mesothelioma.

Indexed as

MesotheliomaMicroRNAsNanoparticlesPeptidesAnimalsAntineoplastic AgentsCell Line, TumorHumansKineticsMicePolyelectrolytesAntineoplastic AgentsMicroRNAsPeptidesPolyelectrolytesconfined impinging jet mixerflash nanocomplexationgene therapyhydrogelsmicroRNA‐peptide nanoparticlespolyelectrolyte complexRNA delivery

Identifiers

PMID38532642
PMCPMC11176031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.